376 related articles for article (PubMed ID: 2738403)
21. [The immune complex pathogenesis of experimental membranous glomerulopathy (Heymann nephritis) and its significance in human glomerular disease].
Kerjaschki D
Verh Dtsch Ges Pathol; 1989; 73():24-35. PubMed ID: 2482609
[TBL] [Abstract][Full Text] [Related]
22. Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis.
Pruchno CJ; Burns MM; Schulze M; Johnson RJ; Baker PJ; Alpers CE; Couser WG
Am J Pathol; 1991 Jan; 138(1):203-11. PubMed ID: 1987766
[TBL] [Abstract][Full Text] [Related]
23. Rapid and severe proteinuria induced in rats by antibody against cultured rat glomerular epithelial cells.
Kawaguchi M; Yamada M; Kawaguchi S; Ohshima K; Moritoh C; Wada H
J Clin Lab Immunol; 1993; 40(2):77-89. PubMed ID: 7932631
[TBL] [Abstract][Full Text] [Related]
24. Immunoelectron microscopy of cationized bovine serum albumin-induced glomerulonephritis in the rabbit.
al-Nawab MD; Bass PS; Das AK; Davies DR
J Pathol; 1992 May; 167(1):33-40. PubMed ID: 1625056
[TBL] [Abstract][Full Text] [Related]
25. Complement C5b-9 induces receptor tyrosine kinase transactivation in glomerular epithelial cells.
Cybulsky AV; Takano T; Papillon J; McTavish AJ
Am J Pathol; 1999 Nov; 155(5):1701-11. PubMed ID: 10550326
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical study of the membrane attack complex of complement and S-protein in idiopathic and secondary membranous nephropathy.
Lai KN; Lo ST; Lai FM
Am J Pathol; 1989 Sep; 135(3):469-76. PubMed ID: 2675624
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
Camussi G; Noble B; Van Liew J; Brentjens JR; Andres G
J Immunol; 1986 Mar; 136(6):2127-35. PubMed ID: 3485141
[TBL] [Abstract][Full Text] [Related]
28. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats.
Baker PJ; Ochi RF; Schulze M; Johnson RJ; Campbell C; Couser WG
Am J Pathol; 1989 Jul; 135(1):185-94. PubMed ID: 2672823
[TBL] [Abstract][Full Text] [Related]
29. Complement C5b-9-mediated arachidonic acid metabolism in glomerular epithelial cells : role of cyclooxygenase-1 and -2.
Takano T; Cybulsky AV
Am J Pathol; 2000 Jun; 156(6):2091-101. PubMed ID: 10854230
[TBL] [Abstract][Full Text] [Related]
30. Induction of passive Heymann nephritis in complement component 6-deficient PVG rats.
Spicer ST; Tran GT; Killingsworth MC; Carter N; Power DA; Paizis K; Boyd R; Hodgkinson SJ; Hall BM
J Immunol; 2007 Jul; 179(1):172-8. PubMed ID: 17579035
[TBL] [Abstract][Full Text] [Related]
31. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.
Kerjaschki D; Farquhar MG
J Exp Med; 1983 Feb; 157(2):667-86. PubMed ID: 6337231
[TBL] [Abstract][Full Text] [Related]
32. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.
Ronco P; Allegri L; Brianti E; Chatelet F; Van Leer EH; Verroust P
Appl Pathol; 1989; 7(2):85-98. PubMed ID: 2567175
[TBL] [Abstract][Full Text] [Related]
33. Augmented expression of glomerular basement membrane specific type IV collagen isoforms (alpha3-alpha5) in experimental membranous nephropathy.
Minto AW; Kalluri R; Togawa M; Bergijk EC; Killen PD; Salant DJ
Proc Assoc Am Physicians; 1998; 110(3):207-17. PubMed ID: 9625527
[TBL] [Abstract][Full Text] [Related]
34. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria.
Hara M; Batsford SR; Mihatsch MJ; Bitter-Suermann D; Vogt A
Lab Invest; 1991 Aug; 65(2):168-79. PubMed ID: 1881120
[TBL] [Abstract][Full Text] [Related]
35. Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane.
Kerjaschki D; Miettinen A; Farquhar MG
J Exp Med; 1987 Jul; 166(1):109-28. PubMed ID: 2885390
[TBL] [Abstract][Full Text] [Related]
36. The cytoprotective role of Ras in complement-mediated glomerular epithelial cell injury.
Huynh C; Ren G; Papillon J; Guillemette J; Takano T; Cybulsky AV
Clin Immunol; 2009 May; 131(2):343-53. PubMed ID: 19138568
[TBL] [Abstract][Full Text] [Related]
37. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.
Floege J; Kriz W; Schulze M; Susani M; Kerjaschki D; Mooney A; Couser WG; Koch KM
J Clin Invest; 1995 Dec; 96(6):2809-19. PubMed ID: 8675651
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis.
Remuzzi A; Monaci N; Bonassi ME; Corna D; Zoja C; Mohammed EI; Remuzzi G
Lab Invest; 1999 Dec; 79(12):1501-10. PubMed ID: 10616201
[TBL] [Abstract][Full Text] [Related]
39. Anti-Fx1A produces complement-dependent cytotoxicity of glomerular epithelial cells.
Quigg RJ; Cybulsky AV; Jacobs JB; Salant DJ
Kidney Int; 1988 Jul; 34(1):43-52. PubMed ID: 3172636
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical studies of vitronectin, C5b-9, and vitronectin receptor in membranous nephropathy.
Ogawa T; Yorioka N; Yamakido M
Nephron; 1994; 68(1):87-96. PubMed ID: 7527506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
